Organigram Launches New Wellness Brand, Monjour
November 18 2021 - 6:00AM
Business Wire
Monjour’s CBD-forward product assortment is
designed to complement one’s daily wellness routine
Organigram Holdings Inc. (“Organigram” or the
“Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of
Organigram Inc., a leading Canadian producer of cannabis, is
pleased to announce the launch of Monjour, the Company’s new
wellness brand, offering high-quality, CBD-forward products for
consumers seeking easy and convenient ways to incorporate
cannabidiol (CBD) into their daily wellness routine. Monjour’s
first offerings in this emerging category include both
vegan-friendly as well as sugar-free soft chews, both in assorted
flavours.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20211118005591/en/
(Photo: Business Wire)
Organigram’s strategic approach to product development remains
focused on the needs and preferences of Canadian consumers. “At
Organigram, we are committed to innovation, and keeping consumers
at the heart of every product we launch,” says Beena Goldenberg,
CEO, Organigram. “By paying close attention to how Canadians are
thinking about and consuming CBD, we’ve been able to develop and
deliver an exciting new line of products while taking advantage of
a growing CBD edibles market, currently with limited competitive
offerings.”
Market research suggests consumers are looking for affordable,
dosage-controlled, and flavourful ways of consuming CBD.i Monjour
gummies are offered in both Berry Medley and Citrus Medley flavour
options. Both vegan-friendly Monjour and sugar-free Monjour Bare
varieties are available in 30-count packs with 20mg of CBD per
piece, totalling 600mg per bottle.
Monjour is the latest product line to be produced in the
recently acquired Edibles and Infusions (“EIC”) facility located in
Winnipeg, Manitoba. “Leveraging EIC’s highly-efficient production
technology means we can produce high-quality, low-cost
confectionery products. As a result, we can expand our
edibles-based business, offer products at consumer-friendly prices,
and continue to deliver value to our shareholders,” says
Goldenberg.
Estimates suggest that the Canadian CBD market as a whole is
expected to deliver $263M in sales in 2022.ii
For more information about Monjour, visit
https://monjourwellness.com/ or on Instagram @monjourwellness.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and
TSX listed company whose wholly owned subsidiaries include:
Organigram Inc., a licensed producer of cannabis and
cannabis-derived products in Canada and The Edibles and Infusions
Corporation, a licensed manufacturer of cannabis-infused soft chews
and candy in Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company’s global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Indi, Bag o’ Buds, SHRED, SHRED’ems,
Monjour and Trailblazer. Organigram’s facility is located in
Moncton, New Brunswick with another manufacturing facility in
Winnipeg, Manitoba. The Company is regulated by the Cannabis Act
and the Cannabis Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans,” “expects,” “estimates,”
“intends,” “anticipates,” “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may,” “could,” “would,” “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
the market position and reception of Monjour and other products
from time to time, changing competitive conditions, changing
consumer preferences, the relative performance of products in
different provincial jurisdictions and factors and risks as
disclosed in the Company’s most recent annual information form,
management’s discussion and analysis and other Company documents
filed from time to time on SEDAR (see www.sedar.com) and filed or
furnished to the Securities and Exchange Commission on EDGAR (see
www.sec.gov). Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date
of this press release. Performance in certain provinces may not be
indicative of performance in other provinces. Although the Company
believes that the assumptions and factors used in preparing the
forward-looking information in this news release are reasonable,
undue reliance should not be placed on such information and no
assurance can be given that such events will occur in the disclosed
time frames or at all. The forward-looking information included in
this news release are made as of the date of this news release and
the Company disclaims any intention or obligation, except to the
extent required by law, to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise.
i “US CBD Consumer Insights Report,” Brightfield Group, 2021. ii
“Canada CBD Market Insights Report,” Brightfield Group, 2020.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211118005591/en/
For Investor Relations enquiries:
Investors@organigram.ca
For Media enquiries: Megan McCrae Senior Vice-President
of Marketing and Communications megan.mccrae@organigram.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2023 to Apr 2024